ACDIMA International
泛阿拉伯制药和医疗器械公司于 1976 年由阿拉伯经济统一委员会成立。
ACDIMA（阿拉伯药品工业和医疗器械公司）于1976年3月6日根据阿拉伯经济统一理事会的决议成立，初始资本为6000万科威特第纳尔。该公司在阿拉伯世界销售药品及其子公司的药品。其附属生物等效性 CRO ACDIMA 中心位于安曼。
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Amman, Jordan
- Founded
- 1976
- Website
- acdima.com
- Categories
- 医疗保健用品
- Markets
- 阿拉伯联合酋长国, 沙特阿拉伯, 埃及, 德国, 英国
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-03 Mail server of the company domain
- web-presence-since (green), checked 2026-08-03 Internet Archive (Wayback)
- sanctions-clear (green), checked 2026-08-03 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- debarment-clear (green), checked 2026-08-03 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- domain-registered (green), checked 2026-08-03 Domain registry record
Claimed certifications, not confirmed by us
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)